A detailed history of Formidable Asset Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Formidable Asset Management, LLC holds 37,427 shares of RPRX stock, worth $962,248. This represents 0.19% of its overall portfolio holdings.

Number of Shares
37,427
Previous 40,610 7.84%
Holding current value
$962,248
Previous $1.14 Million 0.35%
% of portfolio
0.19%
Previous 0.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $87,405 - $99,723
-3,183 Reduced 7.84%
37,427 $1.14 Million
Q4 2023

Feb 07, 2024

SELL
$26.21 - $29.22 $24,532 - $27,349
-936 Reduced 2.25%
40,610 $1.14 Million
Q3 2023

Nov 09, 2023

BUY
$26.26 - $31.38 $131,877 - $157,590
5,022 Added 13.75%
41,546 $1.13 Million
Q2 2023

Aug 15, 2023

BUY
$29.6 - $36.56 $108,513 - $134,028
3,666 Added 11.16%
36,524 $1.12 Million
Q1 2023

May 09, 2023

BUY
$32.77 - $39.4 $266,649 - $320,597
8,137 Added 32.92%
32,858 $1.18 Million
Q4 2022

Feb 07, 2023

BUY
$39.17 - $44.04 $134,392 - $151,101
3,431 Added 16.12%
24,721 $977,000
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $22,611 - $25,316
567 Added 2.74%
21,290 $856,000
Q2 2022

Aug 16, 2022

BUY
$37.53 - $44.22 $79,976 - $94,232
2,131 Added 11.46%
20,723 $872,000
Q1 2022

May 04, 2022

BUY
$37.46 - $42.44 $312,791 - $354,374
8,350 Added 81.53%
18,592 $724,000
Q4 2021

Feb 07, 2022

SELL
$35.17 - $42.48 $254,560 - $307,470
-7,238 Reduced 41.41%
10,242 $408,000
Q3 2021

Nov 10, 2021

BUY
$36.14 - $42.24 $33,248 - $38,860
920 Added 5.56%
17,480 $632,000
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $659,916 - $772,192
16,560 New
16,560 $660,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.